Ductal adenocarcinoma

Ductal adenocarcinoma

A malignant tumor arising from the duct cells within a gland.
References in periodicals archive ?
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers in the world, with an average survival time of less than six months and an overall 5-year survival rate of less than 6%, and is related with aggressive growth and a high rate of metastasis.
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal epithelial malignancies.
Reappraisal of total pancreatectomy in 45 patients with pancreatic ductal adenocarcinoma in the modern era using matched-pairs analysis: Multicenter Study Group of Pancreatobiliary Surgery in Japan.
In both normal and chemo-resistant pancreatic ductal adenocarcinoma cell cultures, the curcumin essential oil complex was tested for its ability to inhibit self-renewal and differentiation, also known as "stemness.
The institute's decision means that adult patients with metastatic pancreatic ductal adenocarcinoma could have access to Abraxane in combination with gemcitabine as a treatment option via the NHS in instances when other combination chemotherapies are unsuitable and they would otherwise have gemcitabine monotherapy.
22%) of ductal adenocarcinoma and 2/93 cases of signet ring cell variant of adenocarcinoma; 1/120 diagnosed as a case of prostatitis, 5/120 cases as atypical glands suspicious for malignancy and 3/120 cases as high-grade PIN.
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages.
However, based on the results of the pathological examination, we withdrew the diagnosis of ductal adenocarcinoma (T3bN1M0).
Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center today announced a collaboration focused on developing innovative medicines for pancreatic ductal adenocarcinoma (PDAC).
It is important to differentiate SPTs from ductal adenocarcinoma.
Prostatic ductal adenocarcinoma is the most common of the non-acinar subtypes and is defined by characteristic morphologic features.
The 56 chapters cover ductal adenocarcinoma of the pancreas, periampullary cancers, cystic neoplastic lesions and endocrine neoplasms of the pancreas, and chronic pancreatitis with inflammatory tumor of the pancreas, and address histologic classification, carcinogenesis, presentation, the risks and benefits of specific procedures, chemotherapy, survival, and other topics.